Alkermes Plc (ALKS)

10:04 AM

Insider Sell Alert: David Gaffin Sells Shares of Alkermes PLC - GuruFocus

10:04 AM

08:26 AM

Alkermes (NASDAQ:ALKS) EVP Sells $70,315.38 in Stock - MarketBeat

08:26 AM

07:56 AM

Alkermes (ALKS) EVP David Gaffin sells 2,034 shares in 10b5-1 trade - Stock Titan

07:56 AM

05:04 AM

Alkermes (NASDAQ: ALKS) 2026 proxy outlines CEO change, $1.48B 2025 revenue and Avadel acquisition - Stock Titan

05:04 AM

04:16 AM

Alkermes plc (NASDAQ: ALKS) Form 144 lists affiliate sale amounts - Stock Titan

04:16 AM

05:23 AM

Is Alkermes (ALKS) Building a Durable Sleep-Disorder Franchise With Its Brilliance Phase 3 Bet? - simplywall.st

05:23 AM

05:03 AM

Alkermes Announces Launch of 4th Annual Alkermes Pathways Research Awards® Program - CSRwire

05:03 AM

Apr 03, 2026

Alkermes Starts Phase 3 Program for Narcolepsy Drug Candidate Alixorexton - Sleep Review

Apr 03, 2026

Apr 02, 2026

Alkermes plc (ALKS) stock price, news, quote and history - uk.finance.yahoo.com

Apr 02, 2026

Apr 02, 2026

Craig Hopkinson Sells 9,000 Shares of Alkermes (NASDAQ:ALKS) Stock - MarketBeat

Apr 02, 2026

Apr 02, 2026

ALKS Stock Price, Quote & Chart | ALKERMES PLC (NASDAQ:ALKS) - ChartMill

Apr 02, 2026

Apr 02, 2026

Alkermes plc (NASDAQ:ALKS) Launches Phase II Trial of ALKS 2680 for Idiopathic Hypersomnia - MSN

Apr 02, 2026

Apr 02, 2026

Top 2 Health Care Stocks That May Implode In April - Sahm

Apr 02, 2026

Apr 01, 2026

Alkermes launches phase 3 trials for narcolepsy drug alixorexton By Investing.com - Investing.com Australia

Apr 01, 2026

Apr 01, 2026

Alkermes stock hits 52-week high at $36.46 By Investing.com - Investing.com Canada

Apr 01, 2026

Apr 01, 2026

Alkermes (ALKS) Advances Alixorexton into Phase 3 Trials for Nar - GuruFocus

Apr 01, 2026

Apr 01, 2026

Alkermes (NASDAQ:ALKS) Sets New 1-Year HighStill a Buy? - MarketBeat

Apr 01, 2026

Apr 01, 2026

Alkermes stock hits 52-week high at $36.46 - Investing.com

Apr 01, 2026

Apr 01, 2026

Lilly’s $7.8 Billion Bet Takes It Beyond Obesity Into Sleep - Bloomberg.com

Apr 01, 2026

Apr 01, 2026

Alkermes launches phase 3 trials for narcolepsy drug alixorexton - Investing.com

Apr 01, 2026

Apr 01, 2026

Alkermes Announces Initiation of Phase 3 Brilliance Studies Evaluating Alixorexton for the Treatment of Narcolepsy Type 1 and Type 2 - Yahoo Finance

Apr 01, 2026

Apr 01, 2026

Alkermes (ALKS) Nears 52-Week High on Increasing Orexin Receptor Market Interest - Insider Monkey

Apr 01, 2026

Mar 31, 2026

10 Stocks Dominating Today’s Market Surge: ImmunityBio, Alkermes, and More - Insider Monkey

Mar 31, 2026

Mar 31, 2026

Highs Report: What is the target price for Alkermes plc stockEntry Point & Technical Pattern Based Signals - baoquankhu1.vn

Mar 31, 2026

Mar 31, 2026

Lilly shifts from obesity to narcolepsy with $7.8B Centessa buy - BioWorld MedTech

Mar 31, 2026

Mar 31, 2026

Alkermes Shares Surge 15% Following Lilly-Centessa Deal - Intellectia AI

Mar 31, 2026

Mar 31, 2026

Alkermes’ Future: Critical Developments and Financial Outlook - timothysykes.com

Mar 31, 2026

Mar 31, 2026

Alkermes (ALKS) Shares Surge by Nearly 18% in Market Rally - GuruFocus

Mar 31, 2026

Mar 31, 2026

Alkermes PLC (ALKS) Shares Up 18.16% on Mar 31 - GuruFocus

Mar 31, 2026

Mar 31, 2026

Alkermes (NASDAQ:ALKS) Shares Gap UpStill a Buy? - MarketBeat

Mar 31, 2026

Mar 31, 2026

Apellis Pharmaceuticals, Centessa Pharmaceuticals, Agios Pharmaceuticals And Other Big Stocks Moving High - Benzinga

Mar 31, 2026

Mar 31, 2026

Alkermes plc (NASDAQ:ALKS) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Mar 31, 2026

Mar 31, 2026

Insider Sell: Does Alkermes plc offer margin of safety2026 Retail & Trade Opportunity Analysis Reports - baoquankhu1.vn

Mar 31, 2026

Mar 30, 2026

Bank Watch: Can Alkermes plc deliver consistent dividends2026 Big Picture & Low Risk High Win Rate Stock Picks - baoquankhu1.vn

Mar 30, 2026

Mar 30, 2026

Tudor Investment Corp ET AL Acquires New Position in Alkermes plc $ALKS - MarketBeat

Mar 30, 2026

Mar 28, 2026

Trading Systems Reacting to (ALKS) Volatility - Stock Traders Daily

Mar 28, 2026

Mar 27, 2026

Alkermes plc (NASDAQ: ALKS) AGM May 20, 2026 — CEO succession, proxy votes - Stock Titan

Mar 27, 2026

Mar 27, 2026

Why Is Alkermes (ALKS) Down 2.6% Since Last Earnings Report? - Yahoo Finance

Mar 27, 2026

Mar 26, 2026

Vanguard realignment; no Alkermes (NASDAQ: ALKS) shares reported - Stock Titan

Mar 26, 2026

Mar 26, 2026

Alkermes (NASDAQ:ALKS) Stock Rating Upgraded by Truist Financial - MarketBeat

Mar 26, 2026

Mar 25, 2026

US Stocks Recap: What is the target price for Alkermes plc stock2026 Closing Moves & Growth Focused Stock Reports - baoquankhu1.vn

Mar 25, 2026

Mar 25, 2026

Alkermes PLC (ALKS) Trading 3.57% Higher on Mar 25 - GuruFocus

Mar 25, 2026

Mar 24, 2026

Alkermes (ALKS): Piper Sandler Lowers Price Target, Maintains Ov - GuruFocus

Mar 24, 2026

Mar 24, 2026

Piper Sandler Issues Pessimistic Forecast for Alkermes (NASDAQ:ALKS) Stock Price - MarketBeat

Mar 24, 2026

Mar 23, 2026

Alkermes announces inaugural Alkermes Pathways APN Research Awards™ program - msn.com

Mar 23, 2026

Mar 21, 2026

Alkermes plc stock launches inaugural research awards program amid biotech innovation push - AD HOC NEWS

Mar 21, 2026

Mar 21, 2026

If You Invested $1,000 in Alkermes Plc (ALKS) - Stock Titan

Mar 21, 2026

Mar 21, 2026

Alkermes shares rise after revenue beat and upbeat outlook offsets earnings miss - MSN

Mar 21, 2026

Mar 18, 2026

Big Picture: Can Alkermes plc stock outperform in a bear marketMarket Movers & Expert Approved Trade Ideas - baoquankhu1.vn

Mar 18, 2026

Mar 18, 2026

Alkermes Q4 2025 earnings preview - MSN

Mar 18, 2026

Mar 18, 2026

Alkermes outlines $1.73B–$1.84B 2026 revenue target as Avadel acquisition expands commercial reach - MSN

Mar 18, 2026

Mar 17, 2026

Alkermes plc (ALKS) Latest Stock News & Headlines - Yahoo Finance

Mar 17, 2026

Mar 17, 2026

Alkermes CEO Pops Calls 2026 a “Really Exciting Year” as Orexin Agonists Near Narcolepsy Launch - MarketBeat

Mar 17, 2026

Mar 17, 2026

Layoff Watch: Does Alkermes plc offer margin of safety2026 Volatility Report & Consistent Growth Equity Picks - baoquankhu1.vn

Mar 17, 2026

Mar 17, 2026

Holocene Advisors LP Cuts Holdings in Alkermes plc $ALKS - MarketBeat

Mar 17, 2026

Mar 17, 2026

Alkermes appoints new CFO - MSN

Mar 17, 2026